Category: Sleep medicine

Chronic insomnia affects up to 12% of the adult population in Switzerland, with significant impacts on both physical and mental health. A modern treatment developed by Swiss biopharmaceutical company Idorsia, known as the 'Swiss sleep pill,' is QUVIVIQ (daridorexant), a dual orexin receptor antagonist (DORA) that works differently than traditional sedatives by targeting the brain's wakefulness system.

In the United States, up to 40% of the population reports symptoms of daytime sleepiness, with insomnia being a primary cause [1.2.1]. This has led to the widespread use of sedative-hypnotics, but what are Z-category drugs and how do they fit into treatment?

According to a 2022 survey from SleepFoundation.org, over 27% of U.S. adults reported taking melatonin to aid sleep. However, the timing of the dose is critical for efficacy, with the best time to take melatonin depending on the specific sleep issue you are trying to address.